The Valley Desk

NCT02233504 · Interventional trial

Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)

Overall registry status Completed

Early Phase 1

Conditions High Risk MDS or AML Patients

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov